New €23m EU Research Consortium To Accelerate Repurposing

The 24-Member Consortium Underscores EU Commitment to Advancing Repurposed Drugs

 
• By Rosalind Rei

REMEDi4ALL is the latest in a series of European initiatives to develop and centralize drug repurposing R&D. The group will identify, test and validate new indications for existing medicines on top of shaping policies favorable to repurposing.

Repurpose word highlighted dictionary
The REMDi4ALL initiative is set to receive €23m in funding over five years • Source: Shutterstock

More from Value Added Medicines

More from Products